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1. Introduction
  Atopic dermatitis is a common clinical skin disease which 
is often associated with allergic disease[1-3]. According 
to statistics[4-6], about 60% of atopic dermatitis occurs 
in the first year of infant period after birth. Skin lesion 
in childhood was often detected in crimple, back and 
the extensor aspects of the limbs, with manifestations of 
ichenification, invasive plaque. During the adolescence 
and adulthood, lichen-like skin lesion can often be 
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the skin of the mice. Mice in Group D were treated with acetone solution (100 毺L) on the foot pad 
and abdomen after hair removal at the age of 7 weeks, then on ear skin at the age of 8-13 weeks. 
For mice in A, B and C groups, 100 毺L of acetone solution containing 2, 4-dinitrochlorobenzene 
was applied to the foot pad and the abdomen at the age of 7 weeks, then on ear skins at the age of 
8 to 13 weeks. At the age of 7-13 weeks, mice in Group A and Group D were treated with 100 毺L 
saline (i.p.); mice were given dexamethasone (0.1 mL/kg, i.p.) every other day for 7 weeks in Group 
B; mice were treated with BCG polysaccharide nucleic acid (0.5 mg/kg, i.p.) every other day for 
7 weeks in Group C. The ear thickness was measured every week and the scratching frequency 
was recorded 1 times for 10 min a week. The mice were sacrificed after the last administration of 
drugs. IgE, IL-4, IL-10, IL-12 and IFN-毭 in the plasma were detected using ELISA, and RT-PCR 
method was employed to detect the concentrations of IL-4, IL-10, IL-12 and IFN-毭 proteins. 
After HE staining, the lesion degree of inflammation in ear tissue was observed microscopically. 
Results: The ear thickness and scratching frequency of Group A were significantly higher than 
those in group B, C and D (P<0.05), and there was no significant difference between Group B and 
C (P>0.05); the concentrations of IgE, IL-4 and IL-10 in the plasma and the expression of IL-4, 
IL-10 mRNA in the spleen tissues of Group A, B and C were all significantly higher than those of 
Group D (P<0.05); the concentrations of plasma IL-12 and IFN-毭, and spleen protein expression 
of IL-12 and IFN-毭 in Group C mice were significantly higher than those of Group A (P<0.05). 
Histological observation showed obvious ear tissue exudation, erythema, swelling, desquamation 
of skin, and scabbing in Group A. Histopathology of the skin lesion also showed hyperkeratosis, 
focal-parakeratosis, stratum spinosum hypertrophy, mild sponge-like edema, a large number of 
lymphocytes along with plasma cell infiltration in dermis, angiectasis and hyperemia in Group 
A, while degree of ear skin lesion in Group B and D mice was significantly lighter than that of 
Group A.  Conclusions: BCG polysaccharide nucleic acid can significantly reduce the serum IgE 
concentrations, increase the expression of IL-12, IFN-毭 protein, correct the imbalance of Thl/
Th2 in atopic dermatitis mice, and has obvious inhibitory effect on atopic dermatitis in NC/Nga 
mice.
IF: 0.926
Liu-HuiWang et al./Asian Pacific Journal of Tropical Medicine (2014)913-917914
found at flexor sides of the limbs, head and neck. Skin 
lesions can cause different degrees of itching and seriously 
affect the patient’s normal sleeping and quality of life[7]. 
At present, the pathogenesis of atopic dermatitis is not 
fully understood and the recurrence rate is high, which 
makes the treatment more difficult. Therefore, it is of great 
importance to study the pathogenesis and therapy of atopic 
dermatitis. Some studies have confirmed that[8], Thl/Th2 
cells act their immunization effects through the secretion of 
different cytokines. Normally, cytokines produced by Th1 
and Th2 act through the mutual antagonism of the function 
of each other, achieving balance; but in the skin lesion and 
blood of patients suffered from atopic dermatitis type Th2 
cytokines prevail over Th1 cytokines. Based on the above 
equilibrium theory, the authors consider that adjusting the 
balance of Th1/Th2 cytokines and inhibiting the dominant 
response of Th2 will show a positive effect on the treatment 
of atopic dermatitis. BCG polysaccharide nucleic acid is a 
novel immunomodulator extracted from BCG. It is effective 
in treatment of asthma, allergic rhinitis, chronic measles 
and other allergic diseases. It also has therapeutic effect 
on atopic dermatitis[9]. In the present study, to explore the 
treatment effect of BCG polysaccharide nucleic acid on 
atopic dermatitis in mice and its mechanism, NC/Nga mice 
was selected for constrction of atopic dermatitis model and 
intraperitoneal injection of BCG polysaccharide nucleic acid 
treatment was given.
2. Materials and methods
2.1. Experimental animals
  Forty specific pathogen-free (SPF) NC/Nga mice, regardless 
of gender, at the age of 6 weeks, weighing 10-23 g were 
purchased from Charles River Laboratories, Japan. The mice 
were made to acclimatize to the environment by clean and 
full-nutrient feeding at temperature (23依3) 曟 and humidity 
(50依10)%. Animals were allowed to have free access to diets 
and water with lighting from 8 am to 8 pm every day. The 
dealing of experimental animals was performed according to 
Regulations for the Administration of Affairs Concerning Ex-
Perimental Animals.
2.2.  Apparatuses and reagents
  BioTek Elx 800 automatic plate reader and fluorescent 
inverted microscope were produced by Gene companies 
(USA); Rotor-Gene 3000 fluorescence-based quantitative 
PCR was produced by Corbett Company (Australia). 2, 
4-Dinitrochlorobenzene, IL-4, IL-10, IL-12 and IFN-毭 
primers were provided by Shanhai Yingjun Biotechnology 
Co., LTD. (China). BCG polysaccharide nucleic acid was 
procured from Jiuzhi Tang, Siqi Biological Pharmaceutical 
Co., LTD (Hunan, China). Acetone, dexamethasone and 
sodium sulfide were from Chemical Reagent Factory of 
Hunan Normal University (Hunan, China). Mice, IgE, IL-4, 
IL-10, IL-12, IFN-毭 and ELISA kits were purchased from 
Invitrogen (USA).
2.3. Construction of atopic dermatitis and experiment 
protocols
  Forty NC/Nga mice were selected and randomly divided 
into Group A (model group), Group B (dexamethasone 
treatment group), Group C (BCG polysaccharide nucleic 
acid treatment group) and Group D (control group) with 
10 mice in each group. Atopic dermatitis model in mice 
were constructed by applying 2, 4-dinitrochlorobenzene 
on the skin of the mice. At the age of 7 weeks, mice in 
Group D were treated with acetone solution (100 毺L) on 
the foot pads and abdomens after hair removal; and at the 
age of 8-13 weeks, acetone solution (100 毺L) was applied 
on ear skin of the Group D mice. For mice in Group A, B 
and C, at the age of 7 weeks, 100 毺L of acetone solution 
containing 5% 2, 4-dinitrochlorobenzene was applied to the 
foot pad and the abdomen after removal of hair; and at the 
age of 8 to 13 weeks, 100 毺L acetone solution containing 
2, 4-dinitrochlorobenzene (0.1%) was applied once a week 
on their ear skins. At the age of 7-13 weeks, Group A and 
Group D mice were treated with 100 毺L saline (i.p.); Group 
B mice were given dexamethasone (0.1 mL/kg, i.p.) every 
other day for 7 weeks; Group C mice were treated with BCG 
polysaccharide nucleic acid (0.5 mg/kg, i.p.) every other day 
for 7 weeks. 
2.4. Observation
  The ear thickness of the mice in each group was measured 
every week and the scratching frequency was record 1 
times for 10 min every week. The mice were sacrificed after 
the last administration of drugs. Blood was withdrawn and 
concentrations of IgE, IL-4, IL-10, IL-12 and IFN-毭 in 
the plasma were detected using ELISA. After resection of 
the spleens, RT-PCR method was employed to detect the 
concentrations of IL-4, IL-10, IL-12 and IFN-毭 proteins 
in each group; ear tissues were resected for preparation 
of tissue slice. After HE staining, the lesion degree of 
inflammation in ear tissue was observed microscopically.
2.5. Statistical analysis
  Results were processed by using SPSS17.0 statistical 
software, measurement data were expressed as mean依SD. 
Statistical difference was determined by One-way ANOVA 
and student’s t test, P<0.05 was considered as statistically 
significant.
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3. Results
3.1. Ear thickness comparison
   The ear thickness of Group A mice at the age of 8-13 
weeks was significantly higher than that of Group D mice 
(P<0.05). At the age of 9-13 weeks, ear thickness of mice 
in both Group B and C was significantly higher than that 
of Group D, but lower than that of Group A (P<0.05); and 
ear thickness in Group C were lower than that of Group B 
(P>0.05) (Table 1).
3.2. Scratching frequency of mice in each group at different 
time point
  The scratching frequency of Group A, B and C mice was 
significantly higher than that of Group D mice (P<0.05); while 
scratching frequency of Group B and C was significantly 
lower than that of Group A (P<0.05); and the scratching 
frequency of Group C was significantly lower than that of 
Group B (P<0.05) (Table 2). 
3.3. Concentrations of plasma IgE, IL-4, IL-10, IL-12 and 
IFN-毭 in each group
  Concentration of IgE in plasma was significantly higher 
than that of the other three groups (P<0.05); IgE concentration 
was significantly higher in Group B and C than that of group 
D (P<0.05); concentration of IL-4 and IL-10 in plasma in 
Group A was significantly higher than that in Group D 
(P<0.05), while the levels of IL-12 and IFN-毭 in Group A 
mice showed no significant statistical difference compared 
with those of Group D (P>0.05); the concentration of IL-12 
and IFN-毭 in plasma of Group C mice were significantly 
higher than that of Group D (P<0.05), but IL - 4, IL-10 in 
the plasma of Group C mice showed no statistical difference 
compared with those of Group A (P>0.05); IL-4, IL-12 and 
IFN-毭 in the plasma of Group B mice was significantly 
lower than that of group D, and L-10 concentration was 
significantly higher (P<0.05) (Table 3).
3.4. Expression of IL-4, IL-10, IL-12, IFN-毭 mRNA in the 
spleens of mice in each group
  IL-4, IL-10 mRNA expression in the spleen tissues of 
Group A mice was significantly higher (P<0.05) and IL - 
12 mRNA expression was lower (P<0.05) than that of group 
D, and IFN-毭 mRNA expression showed no statistical 
difference compared with that of Group D (P>0.05). After 
treatment, IL-12 and IF-毭 mRNA expression in spleen 
tissue of Group C mice was significantly higher than that of 
Group A (P<0.05), but IL-4 and IL-10 expression showed 
no statistical difference compared with group A (P>0.05). 
IL-4 and IFN-毭 mRNA expression in Group B mice was 
significantly lower than that of Group A (P<0.05), while IL-10 
was significantly higher than that of Group A (P<0.05), and 
IL-12 showed no statistical differences compared with that 
of Group A (P>0.05) (Table 4).
Table 1
Ear thickness of mice in different group (mm).
Group n 7 weeks 8 weeks 9 weeks 10 weeks 11 weeks 12 weeks 13 weeks
A 10 0.30依0.03 0.35依0.02*  0.43依0.03*  0.52依0.03*  0.61依0.06* 0.64依0.06* 0.78依0.04*
B 10 0.29依0.02 0.32依0.02  0.35依0.03#  0.40依0.04#  0.46依0.03#  0.44依0.03# 0.52依0.17#
C 10 0.30依0.03 0.31依0.02  0.35依0.03#  0.39依0.02#  0.42依0.03# 0.43依002# 0.49依0.03#
D 10 0.30依0.02 0.30依0.08 0.31依0.01 0.31依0.01  031依0.02 0.32依0.01 0.32依0.02
*P<0.05 compared with Group D, #P<0.05 compared with Group A.
Table 2 
Scratching frequency of mice in each group at different time point.
Group n 7 weeks 8 weeks 9 weeks 10 weeks 11 weeks 12 weeks 13 weeks
A 10    2.6依0.6*  5.0依1.2*  7.8依1.3*  9.8依2.6*  12.2依2.8* 14.4依1.3*  14.8依1.3*
B 10     2.8依0.8*#   4.8依1.5*#   5.0依1.0*#   6.4依1.5*#     7.2依0.8*#    7.0依1.6*#     7.6依0.9*#
C 10       2.4依0.6*#△      3.6依1.5*#△      3.8依0.8*#△      5.8依1.3*#△       5.6依1.1*#△       6.6依1.3*#△        7.2依0.5*#△
D 10 1.0依1.0 0.8依0.8 0.4依0.1 0.6依0.9 1.0依0.7  1.0依0.7   1.0依0.7
*P<0.05 compared with Group D, #P<0.05 compared with Group A, △P<0.05 compared with Group B.
Table 3
Concentrations of plasma IgE, IL-4, IL-10, IL-12 and IFN-毭 in each group (pg/mL).
Group n IgE (ng/mL) IL-4 IL-10 IL-12 IFN-毭
A 10    174.7依12.64*   91.49依6.32*   50.97依1.67* 40.14依6.15 51.53依3.45
B 10   50.43依5.36*#      75.79依15.34*#    69.53依3.57*#   30.35依2.85*#   40.83依5.78*#
C 10      84.27依9.35*#△    88.44依12.69
*   51.64依3.52* 122.10依4.64*#   73.89依2.39*#
D 10 17.32依3.56 83.95依6.63 43.92依l.37 42.79依3.99 53.26依4.33
*P<0.05 compared with Group D, #P<0.05 compared with Group A, △P<0.05 compared with Group B.
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3.5. Histological observation
  Histological observation showed normal dermis in the 
skin tissues of Group D mice. Obvious focal-parakeratosis, 
hyperkeratosis, mild sponge-like edema, stratum spinosum 
hypertrophy, angiectasis and hyperemia, cell infiltration of 
a large number of lymphocytes and eosinophilic granulocyte 
around blood vessels were observed in Group A mice. While, 
in Group B and C mice only mild hyperkeratosis, milder 
inflammatory cell infiltration and thinner prickie cells 
(compared with Group A mice) were observed (Figure 1).
      
Group A                                                           Group B
Group C                                                           Group D
  
Figure 1. Histological observation of the ear skin of each group (HE, 
×200).
4. Discussion
  Atopic dermatitis, also known as atopic eczema, is a 
common clinical skin disease. Atopic dermatitis can cause 
different degree of pruritus at every stage of the disease 
and the pruritus can be more aggravating at night, seriously 
influencing the quality of the patient’s sleeping and life. At 
present, the pathogenesis of atopic dermatitis is not entirely 
understood and the treatment for the disease is difficult with 
a high recurrence rate[10-13].
  Some studies have confirmed that[14-16], Thl/Th2 cells play 
an immune role through the secretion of different cytokines. 
Normally, the cytokines produced by Th1/Th2 mutually 
antagonize with each other, achieving balance. But in the 
skin lesion and blood plasma of patients suffered from 
atopic dermatitis patients Th2 cytokines are in dominant 
position. Hence, the authors conclude that the imbalance 
of Thl/Th2 play a critical role in the pathogenesis of atopic 
dermatitis. Based on this theory, the authors consider that 
treatment for atopic dermatitis may be achieved by adjusting 
the imbalance between Thl/Th2 cytokines and inhibiting the 
response of Th2.
  The main ingredients of BCG polysaccharide nucleic 
acid are lipopolysaccharide and nucleic acid. It is a 
bacteria lipopolysaccharide extracted from BCG vaccine 
after removing the protein. This will retain the immune 
function of BCG vaccine, and at the same time, reduce 
the adverse reaction. BCG polysaccharide nucleic acid is 
often used in clinical immunotherapy[17-19]. Studies have 
shown that[20-23], after intervention of BCG polysaccharide 
nucleic acid the activity of NF-KB and the expression of IgE 
decreased significantly in patients with atopic dermatitis, 
while the concentration of IFN-毭 and IL-12 increases 
significantly, indicating that BCG polysaccharide nucleic 
acid can promote the expression of Thl and correct the 
imbalance state of Thl/Th2, thus, achieving the cure of 
atopic dermatitis. In the present study, after the treatment 
of BCG polysaccharide nucleic acid on atopic dermatitis 
mice in Group C, histological observation showed only 
mild hyperkeratosis, mild sponge-like edema, infiltration 
of a small amount of inflammatory cells, less skin lesion 
thickness than that of Group A mice and significantly 
decreased and scratching frequency (P<0.05), suggesting that 
BCG polysaccharide nucleic acid can effectively improve 
the skin lesion in mice with atopic dermatitis. In addition, 
at the end of BCG polysaccharide nucleic acid treatment the 
concentrations of IL-12 and IFN-毭 in the plasma of Group 
C mice were remarkably increased, the concentration of 
IgE was decreased and IL-4 and IL-10 was not influenced, 
confirming that BCG polysaccharide nucleic acid can 
effectively promote the secretion of IL-12 and IFN-毭, 
inhibit the production of IgE, thus adjusting the imbalance 
Table 4
Expression of IL-4, IL-10, IL-12, IFN-毭 mRNA in the spleens of mice in each group.
Group n IL-4 IL-10 IL-12 IFN-毭
A 10  1.670依0.850*  0.942依0.458*  0.615依0.132* 51.53依3.45
B 10  1.243依0.451#  1.359依0.463# 0.649依0.319  40.83依5.78#
C 10 1.792依0.650 0.960依0.556  2.206依1.045#  73.89依2.39#
D 10 0.935依0.372 0.624依0.230 0.993依0.296 53.26依4.33
*P<0.05 compared with Group D, #P<0.05 compared with Group A, △P<0.05 compared with Group B.
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of Th1/Th2, realizing its treatment effect.
  The results of the present study shows that BCG 
polysaccharide nucleic acid can remarkably improve the 
skin lesion, decrease the concentration of IgE in the plasma, 
increase the expression of IL-12 and IFN-毭 protein and 
adjust the imbalance of Th1/Th2 in NC/Nga mice with atopic 
dermatitis. BCG polysaccharide nucleic acid has outstanding 
treatment effect on atopic dermatitis mice.
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